Written and maintained by CASRAI Editorial Board
Last updated
Choosing the wrong administration route in a rodent study is both a scientific error and a welfare failure: it can distort pharmacokinetics through the wrong absorption profile, and it can injure the animal in ways that add unplanned variability to the data. This guide covers the four routes most laboratories use for substance dosing in mice and rats — oral gavage, intraperitoneal (IP), subcutaneous (SC), and intravenous (IV) injection — with the volume limits, needle sizing, technique points, and refinement alternatives that a well-run IACUC protocol should already specify. It is scoped strictly to laboratory rodents; it does not cover nasogastric feeding in human clinical care, which uses the same word (“gavage”) but is an entirely different procedure, patient population, and literature.
Why Route Selection Matters for Both Science and Welfare
Absorption rate and bioavailability differ sharply by route. As a general rule, the order from fastest to slowest systemic absorption is IV > IP > IM > SC > PO (oral). A compound dosed by gavage that is poorly absorbed in the gut, or that undergoes significant first-pass hepatic metabolism, will produce a very different exposure curve than the same compound given IP — a distinction that matters when comparing results across studies or replicating someone else’s protocol. The route also determines which volume and needle-gauge limits apply, which in turn determines how much handling and restraint stress the animal experiences and how much tissue trauma a poorly chosen needle or excessive volume can cause. Under the 3Rs framework codified in IACUC oversight, refinement of the dosing procedure itself — not just the choice of anesthetic or endpoint — is squarely part of the welfare review, and the Guide for the Care and Use of Laboratory Animals (National Research Council, 8th edition) is the baseline reference most US IACUCs cite when evaluating whether a proposed route, volume, and frequency are justified for the species and study design.
Oral Gavage
Oral gavage delivers a precise, known dose directly to the stomach via a rigid or flexible feeding needle passed through the mouth and esophagus. It is the most technically demanding of the four routes covered here because the esophagus and trachea sit close together at the back of the mouse or rat’s throat, and a misdirected tube can perforate the esophagus or deliver the dose into the lungs.
Restraint and Insertion
The animal is typically restrained by the scruff (mice) or by hand with the head extended (rats), with the head and body held in as straight a line as practical so the esophagus presents a relatively direct path from the mouth. The gavage needle is passed along the roof of the mouth and advanced gently — it should slide with minimal resistance. If the tube meets resistance, the correct response is to withdraw and reposition, not to push harder; forcing a tube against resistance is a recurring cause of esophageal perforation in published technique reviews. Measuring the approximate distance from the mouth to the last rib (or to a marked point on the needle corresponding to the stomach) before insertion, and not advancing past that point, is standard practice for avoiding over-insertion.
Recognizing Tracheal Misplacement
Signs that a gavage needle has entered the trachea rather than the esophagus include immediate respiratory distress, coughing or gasping, and fluid or bubbling visible at the nose. Any of these signs during or immediately after dosing means the procedure must stop immediately, the tube withdrawn, and the animal monitored closely; the dose should not be assumed to have reached the stomach. This is the injury profile that makes gavage technique, not just gavage volume, the primary welfare consideration for this route — and why institutions typically require documented hands-on competency (not just protocol approval) before staff perform gavage independently.
Needle/Tube Sizing and Maximum Volume
Gavage needle gauge is sized to the animal’s body weight, not a single fixed size. Montana State University’s IACUC guideline on substance administration — itself drawing on the two most widely cited reference papers in this area, Diehl et al. (2001, Journal of Applied Toxicology) and Turner et al. (2011, Journal of the American Association for Laboratory Animal Science) — specifies an 18-gauge gavage needle for mice over 30 g and a 20–30-gauge needle for mice under 30 g, and an 18–20-gauge needle for rats.
Published maximum oral gavage volumes vary by institution and are usually expressed per kilogram of body weight. Montana State’s guideline lists 10–50 mL/kg for mice and 10–40 mL/kg for rats as the acceptable range depending on the vehicle and study justification. On a per-animal basis, the University of Iowa’s Office of Animal Resources gives a practical working maximum of 0.5 mL for a 25 g mouse and 4 mL for a 200 g rat by gavage — equivalent to roughly 20 mL/kg for either species at that reference weight. Given this spread, the conservative default many protocols use as a starting point is approximately 10 mL/kg, with anything above that requiring specific scientific and veterinary justification in the IACUC protocol rather than being assumed acceptable. Always confirm your own institution’s current SOP and consult the attending veterinarian before exceeding a published range.
Intraperitoneal (IP) Injection
IP injection deposits substance into the peritoneal cavity, where it is absorbed relatively quickly across the peritoneal membrane — the second-fastest route after IV. It is widely used in rodent studies because it tolerates larger volumes than SC or IM and does not require the technical precision of IV access or the esophageal navigation of gavage.
Quadrant Selection and Technique
The standard technique is to restrain the animal with the head tilted slightly down (so abdominal organs shift cranially) and inject into the lower left or lower right abdominal quadrant, avoiding the midline and the upper abdomen. This quadrant placement is deliberate: it keeps the needle away from the cecum, bladder, and other viscera that sit more centrally, reducing the risk of visceral puncture. The needle is inserted at a shallow angle (commonly cited as roughly 10–30 degrees relative to the body wall) rather than perpendicular, to reduce the chance of driving through the abdominal wall into an organ. Before injecting, the plunger should be aspirated slightly; if blood, urine, or gut content appears in the syringe, the needle must be withdrawn and repositioned rather than injected, since it indicates the needle has entered a vessel or organ rather than the peritoneal cavity.
Needle Gauge and Maximum Volume
Needle gauge recommendations for rodent IP injection are not perfectly consistent across institutions, and it is worth knowing both figures rather than treating either as universal. The University of Iowa’s chart specifies 21-gauge for IP injection in both a 25 g mouse (0.5 mL maximum) and a 200 g rat (4 mL maximum). Montana State’s broader parenteral-injection guideline instead recommends 25–30-gauge needles for rodent injections generally, on the principle that the smallest gauge that will still reliably deliver the intended volume and viscosity minimizes tissue trauma; it lists an IP volume range of 20–80 mL/kg for mice and 10–20 mL/kg for rats. Reconciling the two: the conservative, widely usable figure is a 25–27-gauge needle at roughly 10–20 mL/kg for either species, with your institution’s specific SOP and attending veterinarian as the deciding authority for anything outside that range or for higher-viscosity vehicles that require a larger-bore needle to inject at all.
Subcutaneous (SC) Injection
SC injection deposits substance into the loose connective tissue under the skin, typically over the shoulders/dorsal scruff or the flank. Absorption is slower than IP or IV, which makes SC a common choice for sustained-release formulations, vaccines, and substances that would be irritating if delivered into the peritoneal cavity. The University of Iowa’s chart gives a maximum of 0.25 mL (20-gauge needle) for a 25 g mouse and 1 mL (20-gauge) for a 200 g rat; Montana State’s guideline expresses this as a range of 10–40 mL/kg for mice and 5–10 mL/kg for rats. As with the other routes, larger volumes can be split across two injection sites rather than concentrated at one, which reduces local skin tension and discomfort.
Intravenous (IV) Injection
IV injection is the fastest-acting route and is technically the most demanding, since it requires reliable venous access — in mice and rats this is almost always the lateral tail vein, occasionally the saphenous or dorsal penile vein. Because absorption is immediate and complete, IV also carries the least tolerance for dosing error: there is no depot effect to buffer an incorrect volume or concentration. The University of Iowa’s chart lists a maximum of 0.625 mL (25-gauge) for a 25 g mouse and 4 mL (23-gauge) for a 200 g rat. Montana State’s guideline distinguishes bolus from infusion: roughly 5 mL/kg for a slow bolus given over about a minute, versus up to 25 mL/kg for infusion at a maximum rate of 3 mL/min, for both mice and rats. Warming the vehicle to body temperature before injection is a standard precaution for IV delivery of any appreciable volume.
Quick-Reference: Volumes and Needle Gauge by Species and Route
The table below reconciles the University of Iowa’s per-animal reference figures (25 g mouse, 200 g rat) with Montana State University’s per-kilogram ranges. Where the two diverge, both are shown rather than collapsed into a single number — treat the lower end of the range as the conservative default and confirm your own institution’s current SOP before dosing.
| Route | Mouse (~25 g) | Rat (~200 g) | Typical needle gauge |
|---|---|---|---|
| Oral gavage (PO) | 0.5 mL (~10–50 mL/kg range) | 4 mL (~10–40 mL/kg range) | 18 G (mouse >30 g) or 20–30 G (mouse <30 g); 18–20 G (rat) |
| Intraperitoneal (IP) | 0.5 mL (10–80 mL/kg range across sources) | 4 mL (10–20 mL/kg range) | 21–27 G (sources vary; 25–30 G recommended for least tissue trauma) |
| Subcutaneous (SC) | 0.25 mL (10–40 mL/kg range) | 1 mL (5–10 mL/kg range) | 20 G |
| Intravenous (IV) | 0.625 mL bolus (~5 mL/kg) | 4 mL bolus (~5 mL/kg); up to 25 mL/kg slow infusion | 23–25 G |
Sources: University of Iowa Office of Animal Resources, “Recommended Volumes of Administered Substances” informational sheet; Montana State University Research Integrity & Compliance, “Substance Administration in Laboratory Animals: Routes, Volumes, and Needle Sizes” (citing Diehl et al. 2001 and Turner et al. 2011).
Acclimation and Handling Training
Every route above is easier on the animal, and produces cleaner data, when the animal has been acclimated to handling before the first dosing session rather than restrained for the first time on dosing day. Brief, repeated handling sessions in the days before a study begins reduce the stress response measurable during subsequent restraint and injection, which matters both for welfare and because acute stress hormones can confound the physiological endpoints many rodent studies are measuring. Technique competency is separate from protocol approval: most institutions require personnel to demonstrate hands-on proficiency for each route — typically observed by veterinary staff or an experienced trainer — before performing it independently on study animals, and to document that training. Personnel with animal contact are also generally required to be enrolled in the institution’s occupational health program for animal research personnel before starting hands-on work.
Refinement Alternatives to Gavage and Injection
Where the study design allows it, several voluntary approaches avoid the restraint and needle/tube exposure inherent to gavage and injection altogether: training animals to voluntarily consume a small, flavored volume of drug solution from a syringe tip or dish; incorporating the substance into a palatable gel or jelly the animal eats voluntarily; or administering via the diet or drinking water for compounds where dose precision at the individual-animal level is less critical than group-level exposure. NC3Rs (nc3rs.org.uk) maintains practical resources and case studies on establishing voluntary and dietary dosing methods, and is generally the first place to check whether a refinement of this kind has already been validated for a similar compound or study design before defaulting to gavage or injection. These methods require more validation work up front (confirming the animal reliably consumes the full intended dose) but can meaningfully reduce cumulative procedural stress in longer-duration studies.
Vehicle Selection: pH, Osmolality, and Solubility
The vehicle a compound is dissolved or suspended in is as much a welfare and data-quality variable as the route itself. A vehicle with pH far outside physiological range, or osmolality substantially hypertonic or hypotonic relative to plasma, can cause local tissue irritation or pain at the injection site (SC, IP) or hemolysis and vessel damage (IV), independent of the test compound. As a general principle, vehicles should be as close to physiological pH and isotonic as the compound’s solubility allows, and any vehicle outside that range should be specifically justified in the IACUC protocol along with a rationale for why a gentler formulation was not feasible.
Recognizing Adverse Effects After Dosing
Post-dosing observation should watch for both procedure-related and compound-related effects: at the injection or gavage site, look for swelling, redness, discharge, or self-trauma (excessive licking/scratching at the site); systemically, watch for lethargy, hunched posture, reduced food/water intake, weight loss, labored breathing, or abnormal gait. For gavage specifically, delayed-onset respiratory signs (rather than the immediate distress associated with tracheal misplacement) can indicate aspiration and warrant veterinary evaluation. Institutions typically require a defined observation period and documented body-condition/weight monitoring schedule as part of the approved protocol, with pre-specified humane endpoints if adverse effects exceed a defined severity.
Record-Keeping
For every dosing event, standard practice is to record the date and time, animal identifier, route, exact volume and concentration delivered, needle/tube gauge used, the person performing the procedure, and any observed complications (failed attempt, aspiration on IP injection, suspected tracheal placement on gavage, etc.). This record serves two purposes: it lets a study team distinguish a genuine biological result from a dosing-technique artifact, and it is what an IACUC or an AAALAC site visit will ask to see as evidence that the approved protocol’s volumes, routes, and frequencies are actually what is being performed.
What the IACUC Protocol Must Specify, by Route
A protocol authorizing substance administration should specify, for each route used: the species and strain, maximum volume and concentration (with justification if outside standard institutional ranges), needle/tube gauge, frequency and duration of dosing, the specific personnel or personnel categories qualified to perform the procedure (and how that competency is documented), the vehicle and its rationale, and the humane endpoints and monitoring plan. This level of route-by-route detail is what the IACUC review process is built to evaluate, consistent with the Guide for the Care and Use of Laboratory Animals‘ expectation that procedures be justified for the specific study rather than defaulted to. Deviations from the approved route, volume, or frequency — including an unplanned tracheal misplacement on gavage or a failed IP attempt that required a second injection — are generally required to be reported to the IACUC as a protocol deviation, and a pattern of deviations on a given route is one of the more common triggers for a retraining requirement or a veterinary consult before further dosing proceeds. See CASRAI’s guide to animal research ethics, the 3Rs, and IACUC oversight for how this deviation-reporting expectation fits into the broader compliance framework, and the mouse husbandry guide for the housing and handling context these procedures sit within.
See also The Journal of Research Administration — The Journal of Research Administration (JRA) is SRAI’s peer-reviewed practitioner journal for the research-administration profession.
Frequently Asked Questions
What is the difference between oral gavage and IP injection in mice?
Oral gavage delivers the substance directly to the stomach via a tube passed through the mouth and esophagus, giving a slower, gut-mediated absorption profile and exposing the animal to first-pass hepatic metabolism. IP injection deposits the substance into the peritoneal cavity, where it is absorbed across the peritoneal membrane much faster than by the oral route, though not as fast as IV. The technique risks differ too: gavage’s principal risk is tracheal misplacement or esophageal injury; IP’s principal risk is inadvertent injection into an organ or vessel, which is why aspirating before injecting matters.
What is the maximum safe volume for a mouse gavage?
Published figures vary: University of Iowa’s reference sheet gives 0.5 mL as a practical maximum for a 25 g mouse (about 20 mL/kg), while Montana State University’s guideline allows up to 10–50 mL/kg depending on vehicle and justification. A conservative default many protocols use is approximately 10 mL/kg, with anything higher requiring specific scientific and veterinary justification in the approved IACUC protocol.
How do you know if a gavage needle has entered the trachea instead of the esophagus?
Immediate respiratory distress, coughing or gasping, and fluid or bubbling at the nose are the classic signs. Any of these means stopping immediately, withdrawing the tube, and monitoring the animal closely rather than assuming the dose reached the stomach.
Which abdominal quadrant should be used for IP injection in mice, and why?
The lower left or lower right quadrant, with the head tilted slightly down so abdominal organs shift cranially away from the injection site. This avoids the cecum, bladder, and other centrally located viscera, and reduces the risk of an accidental organ puncture compared to a midline or upper-abdomen injection.
Aspirate the plunger slightly before injecting; if blood, urine, or gut content appears, withdraw and reposition rather than inject.
What needle gauge should I use for a mouse IP injection?
Institutional guidance is not fully consistent: one commonly cited reference chart specifies 21-gauge, while a broader IACUC guideline recommends 25–30-gauge for rodent parenteral injections generally to minimize tissue trauma. A 25–27-gauge needle is a reasonable conservative default for most aqueous vehicles; check your own institution’s SOP, since more viscous vehicles may require a larger-bore needle to inject at all.
Who is qualified to perform gavage or injections on study animals?
This is set at the institutional level, not by this guide: personnel must generally be listed on the IACUC-approved protocol, have completed institutional animal-handling and technique training, and have demonstrated hands-on competency for the specific route (often observed by veterinary staff), in addition to being enrolled in the institution’s occupational health program for animal contact.
Are there alternatives to gavage and injection for dosing rodents?
Yes, where the study design allows: voluntary oral dosing (the animal drinks a small palatable volume from a syringe tip), dietary/drinking-water administration, and palatable gel formulations can all avoid restraint and needle/tube exposure. NC3Rs (nc3rs.org.uk) is the primary resource for validated approaches of this kind and case studies of institutions that have adopted them.
